See All Slides - tctmd.com

Slides

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Case #2: Saphenous Vein Graft PCI (NYP)

Presenter: Regina Deible, Julie Logan, John R. Zimmerman

September 13, 2014

Presentation TCT 2014

Antegrade Guidewires: Technology and Selection

Presenter: J. Aaron Grantham, Masahisa Yamane, Mauro Carlino, Masahiko Ochiai

September 13, 2014

Presentation TCT 2014

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jonghanne Park

September 13, 2014

Presentation TCT 2014

Subclavian and Innominate Intervention: Not as Easy as it Looks

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Douglas E. Drachman

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Akiko Maehara

September 13, 2014

Presentation TCT 2014

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Ganesh Manoharan

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Aly El Banayosy

September 13, 2014

Advertisement

Slides

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Case #2: Saphenous Vein Graft PCI (NYP)

Antegrade Guidewires: Technology and Selection

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Subclavian and Innominate Intervention: Not as Easy as it Looks

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content